Novavax (NVAX) Return on Invested Capital (2011 - 2026)

Novavax's Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Invested Capital rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.02%, down 2.0% from the prior year.
• Return on Invested Capital was 0.01% for Q1 2026 at Novavax, up from 0.22% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.09% in Q1 2022 to a low of 0.22% in Q4 2025.
• Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
• The sharpest annual moves came in 2022 and 2025: Return on Invested Capital soared 32 bps in 2022, then retreated 23 bps in 2025.
• A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2022, then decreased by 25 bps to 0.01% in 2023, then sank by 40 bps to 0.0% in 2024, then tumbled by 4723 bps to 0.22% in 2025, then soared by 97 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.22% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.